Cipla to take BioQuiddity's pain infusion to Europe
Cipla has entered into an alliance with the privately owned US firm BioQuiddity to market the latter's drug infusion system for post-surgical pain management in Europe.
Cipla has entered into an alliance with the privately owned US firm BioQuiddity to market the latter's drug infusion system for post-surgical pain management in Europe.